CORRIGENDUM TO "ASSESSMENT OF PREDICTIVE GENOMIC BIOMARKERS FOR RESPONSE TO CISPLATIN-BASED NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER" [EUR UROL 2023;83:313-17].
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].